Update from CredibleMeds

March 31, 2021

Re: Revision to the QTdrugs List

We are writing to inform you that two newly marketed drugs in the US, Ponesimod for treatment of multiple sclerosis and Voclosporin for treatment of lupus nephritis, have been added to the Possible Risk of TdP category.

Also, if you haven’t already, we hope you will try AZCERT’s web-based decision support program, MedSafety Scan®.  It is available at MedSafetyScan.org to help healthcare providers quickly assess a patient’s risk of QT prolongation and detect potentially dangerous drug-drug interactions.

The features of MedSafety Scan are described in detail in a recent article published in Trends in Cardiovascular Medicine titled Assisted prescribing: Clinical decision support with MedSafety Scan

Thank you for your interest and continued support of CredibleMeds.

Ray Woosley and the Scientific Review Committee 

Scientific Review Committee Raymond L. Woosley, MD, PhD
Klaus Romero, MD, MS
C.Will Heise, MD
Tyler Gallo, PharmD
Jared Tate, PharmD
David Woosley, MPH

Members with cardiac conditions may like to consider registering with CredibleMeds to be kept up to date with any changes to the QT drugs to avoid list https://crediblemeds.org/everyone/

More to explorer

myheart hard copy newsletter

Members who subscribed to the myheart hard copy newsletter should have now received it. Read the online version here. Subscribe to myheart

Share on whatsapp
WhatsApp
Share on facebook
Facebook
Share on twitter
Twitter
Share on reddit
Reddit
Share on email
Email